文献速递耳科与耳神经

新型主动经皮骨传导植入设备的系统综述与荟萃分析

Systematic Review and Meta-Analysis of a New Active Transcutaneous Bone Conduction Implant.
PubMed 文献 · Laryngoscope · 2023-09-18

该系统综述与荟萃分析检索多个数据库至2022年9月20日,纳入14项研究15个患者队列(n=314),评估Osia经皮骨传导植入设备在不同类型听力损失中的功能增益、患者报告结局和并发症率。汇总总体平均功能增益为35.0 dB SPL(95%CI 29.12-40.97),传导性/混合性听力损失为37.7 dB SPL(95%CI 26.1-49.3),单侧聋因数据少未能计算。结论认为该设备显示出明确的听力学获益和良好的安全性。

要点

  • 汇总总体平均功能增益为35.0 dB SPL(95%CI 29.12-40.97)。
  • 传导性/混合性听力损失功能增益为37.7 dB SPL(95%CI 26.1-49.3)。
  • 预测取出率0.11%(95%CI 0.00%-1.90%),伤口感染率1.92%(95%CI 0.00%-6.17%)。

核心结论

  • Osia设备在纳入的患者人群中显示出明确的听力学获益和良好的安全性。
  • 研究结果提示频率特异性增益、患者报告结局和单侧聋的听力学获益可能是未来前瞻性研究的领域。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline、Embase、SCOPUS、Cochrane CENTRAL、PROSPERO和Cochrane Library,检索时间从数据库建库至2022年9月20日。
  • 共识别168项研究,其中14项研究15个患者队列(n=314)符合荟萃分析纳入标准。

主要发现

  • 所有类型听力损失的汇总总体平均功能增益为35.0 dB SPL(95%CI 29.12-40.97),与未助听状态相比。
  • 传导性/混合性听力损失的汇总功能增益为37.7 dB SPL(95%CI 26.1-49.3)。
  • 单侧聋的汇总功能增益因报告单侧聋数据的患者队列小未能计算。
  • 与基线听力相比,言语接受阈、信噪比和部分患者报告结局呈改善趋势。
  • 早期并发症率与其他经皮植入设备相似,预测取出率为0.11%(95%CI 0.00%-1.90%),伤口感染率为1.92%(95%CI 0.00%-6.17%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 单侧聋数据报告的患者队列小,未能计算汇总功能增益。
  • 未识别到直接比较经皮设备的研究。
  • 研究结果提示频率特异性增益、患者报告结局和单侧聋的听力学获益可能是未来前瞻性研究的领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This review aims to quantify the pooled functional gain (FG) in different types of hearing loss with the transcutaneous hearing device, Osia (Cochlear, Sydney, Australia) in comparison with the unaided state. Secondary outcomes are patient-reported outcomes measures (PROMs) and complication rates. DATA SOURCES: Medline, Embase, SCOPUS, Cochrane CENTRAL, PROSPERO and Cochrane Library. REVIEW METHODS: Systematic review and meta-analysis of indexed search terms relating to "Osia," "Osseointegration," "Cochlear Implant," and "Bone-Anchored Prosthesis" was performed from database inception to September 20, 2022. RESULTS: Of the 168 studies identified, 14 studies with 15 patient cohorts (n = 314) met inclusion criteria for meta-analysis. Pooled overall mean FG for all types of hearing loss was 35.0 dB sound pressure level (SPL) (95% confidence interval [CI] 29.12-40.97) compared against unaided hearing. Pooled FG for conductive/mixed hearing loss was 37.7 dB SPL (95% CI 26.1-49.3). Pooled single-sided deafness (SSD) FG could not be calculated due to the small patient cohort for whom SSD data was reported. There is a trend toward improvements in speech receptiveness threshold, signal to noise ratio, and some PROMs compared with baseline hearing. Early complication rates demonstrate risks similar to other transcutaneous implants, with a low predicted explantation (0.11%, 95% CI 0.00%-1.90%) and wound infection rate (1.92% [95% CI 0.00%-6.17%]). No articles directly comparing transcutaneous devices were identified. CONCLUSION: The Osia devices demonstrate clear audiologic benefits and a good safety profile for the included patient population. Our study results indicate that frequency-specific gain, PROMs, and the audiological benefit in single-sided deafness may be areas for future prospective research. Laryngoscope, 134:1531-1539, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Key S, Mohamed N, Da Cruz M, et al. Systematic Review and Meta-Analysis of a New Active Transcutaneous Bone Conduction Implant. Laryngoscope. 2023. PMID: 37721219. doi:10.1002/lary.31053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。